releases: http://latta.house.gov/news/documentsingle.aspx?DocumentID=363071
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| http://latta.house.gov/news/documentsingle.aspx?DocumentID=363071 | Latta Comments on President Signing Legislation to Combat Counterfeit Pharmaceuticals | 2013-11-27 | 2013 | 2013-11 | Republican | House | OH | Robert Latta | L000566 | latta.house.gov | legacy | Today, President Obama signed into law H.R. 3204, the Drug Quality and Security Act, sponsored by Congressman Fred Upton (R-MI), which included language based on Safeguarding America's Pharmaceuticals Act of 2013 (H.R. 1919), introduced by Congressman Bob Latta (R-OH) earlier this year. "It is important the President has signed this bipartisan legislation into law today, which represents the culmination of years of work and collaboration from many stakeholders on establishing a secure pharmaceutical supply chain. I am proud to have sponsored H.R. 1919, which was included in this overall legislative package. This law will ensure Americans greater safety when taking prescribed medications and protect them from counterfeit and adulterated drugs." H.R. 3204 establishes a national standard for tracing requirements for pharmaceutical manufacturers, wholesale distributors, pharmacies and repackagers based on changes in ownership. Further, it requires the affiliates of the supply chain, including third-party logistics providers to undertake verification and notification activities regarding suspect or illegitimate products. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |